Core Viewpoint - The article presents a bullish perspective on UnitedHealth Group (NYSE: UNH), suggesting that purchasing the stock during periods of negative headlines could yield future rewards for investors [1]. Group 1 - The stock has faced ongoing negative headlines, yet the author maintains a positive outlook on its potential [1]. - The investment strategy highlighted focuses on strategic buying opportunities, particularly in dividend and value stocks, which has garnered a strong following and high ratings on investment platforms [1].

Back in 2021, Moderna (NASDAQ: MRNA ) shares traded for around $500 per share, so it is amazing to think that at that time, even just 100 shares of this stock would have set you back by about $50,000. However, since then, it seems likeLong-time stock market investor focused on strategic buying opportunities with dividend and value stocks. This investment strategy has resulted in a near 5 star rating on Tipranks.com and over 9,000 followers on Seeking Alpha. Follow me on Twitter for my latest trading ideas: ...